Capabilities and credentials
A cGMP manufacturer, in the facts.
- Australian biosynthesis pharmaceutical manufacturer, founded 2021.
- cGMP manufacturer holding both Schedule 8 and Schedule 9 licences.
- The only psilocybin and MDMA active pharmaceutical ingredient (API) manufacturer in Australia.
- Supplies both active pharmaceutical ingredients (API) and finished dose forms.
- Has supplied 10+ Phase 2 (or later) clinical trials, in Australia and globally.
- TGO 112 and TGO 113 compliant.
- Sustainable process: no petrochemicals, no harsh industrial solvents, no plastic waste.
- Holds finished inventory on hand.
For professional audiences.These facts are provided for prescribers, clinical-trial sponsors and investigators, researchers, and commercial partners. They are not an offer to supply to the public and make no therapeutic claims.
What we believe
What we stand for.
Quality is everything.
Medicine is not a general-purpose product. The standards are set for a reason. We meet them, every time.
Local beats imported.
Critical medicines should be made locally under one quality system, and patients should not be reliant on fragile global supply chains.
Patients come first.
Every decision — what we make and how we make it — starts by understanding the people in need of the medicine.
Team
Pharmaceutical, regulatory, and commerical leadership.
Executive
Board of Directors
